Outpatient Antibiotic Treatment for Uncomplicated Cellulitis
For nonpurulent cellulitis in healthy adults, treat with a beta-lactam antibiotic (cephalexin 500 mg four times daily or dicloxacillin 500 mg four times daily) for 5-6 days, targeting beta-hemolytic streptococci. 1, 2
Treatment Algorithm Based on Clinical Presentation
Step 1: Classify the Cellulitis Type
Nonpurulent cellulitis (no drainage, no exudate, no abscess):
- This is the most common presentation
- Caused primarily by beta-hemolytic streptococci (Group A Strep)
- First-line therapy: Beta-lactam antibiotics targeting streptococci 1
- Cephalexin 500 mg PO four times daily
- Dicloxacillin 500 mg PO four times daily
- Amoxicillin 500 mg PO three times daily
Purulent cellulitis (drainage or exudate present, but no drainable abscess):
- Likely caused by community-acquired MRSA (CA-MRSA)
- First-line therapy: MRSA-active antibiotics 1
- Trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily
- Doxycycline 100 mg twice daily
- Clindamycin 300-450 mg three times daily
Step 2: Duration of Treatment
5-6 days is sufficient for uncomplicated cases 2. The 2021 American College of Physicians guideline specifically recommends 5-6 days for nonpurulent cellulitis, updating the older IDSA recommendation of 5-10 days 1. Extend treatment only if clear signs of infection persist beyond this timeframe.
Step 3: When to Add MRSA Coverage to Beta-Lactam Therapy
Add MRSA coverage to your initial beta-lactam regimen if the patient has:
- Failed to improve after 48-72 hours on beta-lactam therapy 1
- Signs of systemic toxicity (fever, tachycardia, hypotension) 1
- Penetrating trauma
- Known MRSA colonization
- Injection drug use
- Recent MRSA infection
Dual coverage options when both streptococci and MRSA coverage needed:
- Clindamycin alone (covers both) 1
- TMP-SMX or doxycycline PLUS amoxicillin 1
- Linezolid alone (covers both, but expensive) 1
Critical Clinical Pearls
Common Pitfalls to Avoid
Do NOT routinely cover MRSA in nonpurulent cellulitis. Despite rising CA-MRSA rates, the evidence shows beta-hemolytic streptococci remain the primary pathogen in typical cellulitis without purulence 1, 3, 4. Broad-spectrum overuse is common and unjustified 5.
Do NOT use TMP-SMX or doxycycline alone for nonpurulent cellulitis. These agents lack reliable streptococcal coverage 1. If you choose these for suspected MRSA involvement, you must add a beta-lactam.
Do NOT prescribe 10-14 day courses reflexively. The evidence supports shorter courses (5-6 days) for uncomplicated cases 2. Longer durations increase adverse effects and costs without improving outcomes.
When Oral Therapy is Appropriate
Oral antibiotics are as effective as IV therapy for uncomplicated cellulitis 6. Outpatient oral treatment is appropriate when the patient:
- Can take oral medications
- Has no signs of systemic toxicity or sepsis
- Can perform self-monitoring
- Has reliable follow-up within 48-72 hours 2
Antibiotic-Specific Considerations
Clindamycin: Risk of Clostridioides difficile infection is higher than with other oral agents 1. Reserve for cases requiring dual coverage or documented MRSA with beta-lactam allergy.
TMP-SMX: Avoid in third-trimester pregnancy (Category C/D) and infants under 2 months 1. Use caution in elderly patients on ACE inhibitors or with renal insufficiency due to hyperkalemia risk 1.
Tetracyclines: Contraindicated in children under 8 years and pregnancy (Category D) 1.
Evidence Quality and Nuances
The IDSA guidelines from 2011 1, 7, 1, 7, 1 remain the most comprehensive and widely cited, though the 2021 ACP guideline 2 provides important updates on treatment duration based on more recent RCT data. The distinction between purulent and nonpurulent cellulitis is the critical decision point that determines empirical coverage 1.
Research from high CA-MRSA prevalence areas (Hawaii) showed superior outcomes with TMP-SMX over cephalexin 8, but this applies specifically to settings with documented high MRSA rates and should not change the standard approach for typical nonpurulent cellulitis where streptococci predominate 3, 4.